Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly(A) binding protein cytoplasmic 1 pseudogene 6 (PABPC1P6) is a human pseudogene similar in sequence to the functional poly(A) binding protein cytoplasmic 1 (PABPC1), but it is not translated into a functional protein[2][5][6]. Pseudogenes are genetic elements that resemble functional genes but typically lack the ability to produce protein due to accumulated disabling mutations, absence of promoters, or other regulatory sequences[6]. While pseudogenes were once thought to be functionless, some may have regulatory roles as sources of non-coding RNA or by affecting gene expression[4][6]. PABPC1P6 is not recognized as a therapeutic target, receptor, enzyme, or biomarker, and has no known drug interactions or direct disease associations[2][5][6]. Standard databases correctly identify PABPC1P6 as a pseudogene with approved status[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly(A) binding protein cytoplasmic 1 pseudogene 6 (PABPC1P6).